OPEONGO Trademark

Pharmaceutical preparations and substances for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer; Antibodies for medical purposes; Therapeutic antibodies for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer

Drug discovery services; Biochemical analysis services in the field of drug discovery; Biochemical analysis services in the field of medical diagnosis of disease; Biochemical analysis services in the field of drug target discovery; Pharmaceutical drug development services; Drug discovery services for: modulation of the extracellular matrix, prevention and treatment of fibrotic diseases, treating inflammatory diseases, treating age-related diseases, treating degenerative diseases, treating tissue repair, treating regeneration disorders, and chemotherapy; Scientific research for medical purposes in the area of fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, regeneration disorders; Biomedical research in the field of the extra cellular matrix and fibrosis; providing online non-downloadable software for modeling the extracellular matrix for use in drug and target discovery; providing online non-downloadable software for drug discovery in the field of: fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, and regeneration disorders